相关实验视频
Updated: Feb 18, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.5K
躁狂和混合情节住院的抗抑郁药相关风险在双相I型障碍:一个10年的基于人口的队列研究
Diego Hidalgo-Mazzei1,2,3,4,5, Gerard Anmella1,2,3,4, Michele De Prisco1,2,3,4
1Department of Psychiatry and Psychology, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain.
Bipolar disorders
|February 17, 2026
概括
抗抑郁药 (AD) 在双相I型精神障碍 (BD-I) 中的使用会使躁狂/混合发作住院的风险增加30%. 将AD与情绪稳定剂相结合似乎可以减轻这种风险,特别是在年轻的患者中.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床流行病学临床流行病学
背景情况:
- 抗抑郁药 (AD) 在双相I型精神障碍 (BD-I) 中的使用是有争议的,因为可能诱导躁狂/混合发作.
- 在BD-I患者的AD开始后评估住院风险对于治疗安全至关重要.
研究的目的:
- 为了检查患有双相I型精神障碍的患者在开始抗抑郁药物治疗后因躁狂/混合发作而入院的风险.
- 为了比较不同抗抑郁药治疗策略和患者子组的住院风险.
主要方法:
- 7946名BD-I患者 (2010-2019) 的回顾性队列研究,使用电子健康记录.
- 1:1倾向分数匹配创造了3973名AD用户和3973名对照人群,随访时间为12个月.
- 考克斯的比例危险模型分析了住院风险,并调整了临床和人口因素.
主要成果:
- 总体而言,阿尔茨海默病的使用使住院的风险增加了27% (HR=1.27,p=0.008).
- 单独治疗AD的风险最高 (HR=1.51,p<0.001),而AD加情绪稳定剂 (AD+MS) 的风险没有显著增加.
- 年轻患者 (18-35岁) 最容易受到AD单一治疗的影响 (HR=2.36,p<0.001);混合发作的风险高于躁狂.
结论:
- 抗抑郁药的使用在BD-I中增加了大约30%的躁狂/混合发作住院风险.
- 将抗抑郁药与情绪稳定剂相结合可能会降低这种风险.
- 治疗策略应避免AD单一治疗,并考虑个性化的方法,特别是对于年轻的患者和那些容易出现混合发作的人.
更多相关视频
相关概念视频
Mania and Antimanic Drugs: Overview
666
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
666
Bipolar Disorder
1.1K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.1K
Antidepressant Drugs: MAOIs and Other Agents
970
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
970
Psychosis and Antipsychotic Drugs: Overview
957
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
957
Psychosis: Goals of Pharmacotherapy
551
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
551
Antidepressant Drugs: Overview
1.6K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.6K

